Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
- PMID: 8456286
- DOI: 10.1126/science.8456286
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Abstract
PU.1 recruits the binding of a second B cell-restricted nuclear factor, NF-EM5, to a DNA site in the immunoglobulin kappa 3' enhancer. DNA binding by NF-EM5 requires a protein-protein interaction with PU.1 and specific DNA contacts. Dephosphorylated PU.1 bound to DNA but did not interact with NF-EM5. Analysis of serine-to-alanine mutations in PU.1 indicated that serine 148 (Ser148) is required for protein-protein interaction. PU.1 produced in bacteria did not interact with NF-EM5. Phosphorylation of bacterially produced PU.1 by purified casein kinase II modified it to a form that interacted with NF-EM5 and that recruited NF-EM5 to bind to DNA. Phosphopeptide analysis of bacterially produced PU.1 suggested that Ser148 is phosphorylated by casein kinase II. This site is also phosphorylated in vivo. Expression of wild-type PU.1 increased expression of a reporter construct containing the PU.1 and NF-EM5 binding sites nearly sixfold, whereas the Ser148 mutant form only weakly activated transcription. These results demonstrate that phosphorylation of PU.1 at Ser148 is necessary for interaction with NF-EM5 and suggest that this phosphorylation can regulate transcriptional activity.
Similar articles
-
PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.Mol Cell Biol. 1992 Jan;12(1):368-78. doi: 10.1128/mcb.12.1.368-378.1992. Mol Cell Biol. 1992. PMID: 1729611 Free PMC article.
-
Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.J Biol Chem. 1995 Apr 28;270(17):10304-13. doi: 10.1074/jbc.270.17.10304. J Biol Chem. 1995. PMID: 7730336
-
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.Genes Dev. 1995 Jun 1;9(11):1377-87. doi: 10.1101/gad.9.11.1377. Genes Dev. 1995. PMID: 7797077
-
PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer.Mol Cell Biol. 1993 Oct;13(10):6452-61. doi: 10.1128/mcb.13.10.6452-6461.1993. Mol Cell Biol. 1993. PMID: 8413244 Free PMC article.
-
I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.Mol Biol Cell. 1992 Dec;3(12):1339-52. doi: 10.1091/mbc.3.12.1339. Mol Biol Cell. 1992. PMID: 1493333 Free PMC article.
Cited by
-
Transcriptional regulation of the HIV-1 inhibitory factor human mannose receptor 1 by the myeloid-specific transcription factor PU.1.J Virol. 2024 Jan 23;98(1):e0170223. doi: 10.1128/jvi.01702-23. Epub 2023 Dec 11. J Virol. 2024. PMID: 38078733 Free PMC article.
-
Temporal analyses reveal a pivotal role for sense and antisense enhancer RNAs in coordinate immunoglobulin lambda locus activation.Nucleic Acids Res. 2023 Oct 27;51(19):10344-10363. doi: 10.1093/nar/gkad741. Nucleic Acids Res. 2023. PMID: 37702072 Free PMC article.
-
IRF4 as an Oncogenic Master Transcription Factor.Cancers (Basel). 2022 Sep 2;14(17):4314. doi: 10.3390/cancers14174314. Cancers (Basel). 2022. PMID: 36077849 Free PMC article. Review.
-
The Myeloid-Specific Transcription Factor PU.1 Upregulates Mannose Receptor Expression but Represses Basal Activity of the HIV-LTR Promoter.J Virol. 2022 Jul 27;96(14):e0065222. doi: 10.1128/jvi.00652-22. Epub 2022 Jun 29. J Virol. 2022. PMID: 35766490 Free PMC article.
-
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.Leukemia. 2022 Jul;36(7):1781-1793. doi: 10.1038/s41375-022-01594-1. Epub 2022 May 19. Leukemia. 2022. PMID: 35590033 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
